학술논문

Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N).
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p6021-6021, 1p
Subject
Language
ISSN
0732183X